The Best Way To Play This – And Other – COVID-19 Biotech Stocks

2020-06-04 22_28_52-Crop chemist holding in hands molecule model · Free Stock PhotoThe biotech stock highlighted in today’s article is one of the many that has surged over the last few months due to its status as a potential COVID-19 play, with the company in question being the producer of a COVID-19 test. As with all the smaller biotechs that have been experiencing COVID-19-related surges lately, however, the question is whether that surge is sustainable or justified, and what the best way to play the stock (and its counterparts) may be. For more, CLICK HERE.